DEMATELab is a new open-source Python application that unites classical, fuzzy, grey and Z-number DEMATEL analysis with ...
Learn seven design patterns for data science code, from Strategy and Adapter to Command and Proxy, each matched to the ...
Read about Recursive’s Flint AI coding model, its laptop-friendly design, coding benchmarks, open-source license, and Eureka ...
Learn how to write cleaner Python with enumerate, zip, generator expressions, itertools, and functional tools for readable, memory-efficient data processing.
The last time I spoke about Recursion Pharmaceuticals (RXRX), it was with a Seeking Alpha article entitled "Recursion: "Hold" Rating Based On Initial REC-4881 FAP Treatment Data." With respect to this ...
In the high-tech, high-competition AI field, we are seeing new versions of models rolled out by the frontier companies (OpenAI, Google and Anthropic) every month and a half. I included a Release ...
Anthropic and OpenAI researchers raised fresh concerns about recursive self-improvement, the process by which AI helps improve the development of models. Both OpenAI and Anthropic have in recent ...
To improve prognostic prediction and identify key predictors of renal and bladder outcomes in boys with posterior urethral valves (PUV) using machine learning (ML). Patients diagnosed after one year ...
Burmese pythons are an invasive species causing significant harm to the South Florida ecosystem. The annual Florida Python Challenge encourages hunters to help control the growing python population.
Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this tag to personalize your feed and get ...
The up-to-$12 billion artificial intelligence (AI) drug discovery collaboration of Recursion, Roche, and its Genentech subsidiary marked a milestone Wednesday when plans were announced for Recursion ...
Genentech advanced the collaboration's first neuroscience target into a joint early discovery program, providing early evidence that Recursion's platform can generate novel, biologically validated ...